Outcomes of perioperative systemic therapy (ST) in patients with R0 resection of metastatic colorectal cancer (mCRC).

被引：0
|
作者：
Lee-Ying, Richard M.
Renouf, Daniel John
Lim, Howard John
Speers, Caroline
Cheung, Winson Y.
机构：
[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[2] BC Canc Agcy, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.496
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
496
引用
收藏
页数：1
相关论文
共 50 条
  • [1] First-line folfoxiri followed by R0 surgical resection of metastases in unresectable metastatic colorectal cancer (MCRC) patients (PTS)
    Masi, G.
    Loupakis, F.
    Bursi, S.
    Barbara, C.
    Barletta, M. T.
    Baldi, G.
    Cupini, S.
    Brunetti, I.
    Pfanner, E.
    Lencioni, M.
    Di Donato, S.
    Mentuccia, L.
    Fanchini, L.
    Sonaglio, C.
    Fea, E.
    Allegrini, G.
    Andreuccetti, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 21 - 21
  • [2] A R0 Resection Case of Initially Unresectable Metastatic Pancreatic Cancer Downstaged by FOLFIRINOX Therapy
    Sasaki, Takashi
    Isayama, Hiroyuki
    Aoki, Taku
    Tanaka, Mariko
    Hamada, Tsuyoshi
    Nakai, Yousuke
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Morikawa, Teppei
    Fukayama, Masashi
    Kokudo, Norihiro
    Koike, Kazuhiko
    PANCREAS, 2014, 43 (06) : 972 - 974
  • [3] Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis
    Dai Shida
    Takefumi Yoshida
    Taro Tanabe
    Shunsuke Tsukamoto
    Hiroki Ochiai
    Yukihide Kanemitsu
    Annals of Surgical Oncology, 2018, 25 : 1646 - 1653
  • [4] Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis
    Shida, Dai
    Yoshida, Takefumi
    Tanabe, Taro
    Tsukamoto, Shunsuke
    Ochiai, Hiroki
    Kanemitsu, Yukihide
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (06) : 1646 - 1653
  • [5] Long term outcome of patients with R0 resection of locally peritoneal metastasized colorectal cancer
    Brandl, A.
    COLOPROCTOLOGY, 2018, 40 (03) : 221 - 222
  • [6] First line irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI) enables R0 surgical resection of metastases in patients (pts) with initally unresectable metastatic colorectal cancer (MCRC)
    Masi, Gianluca
    Cupini, Samanta
    Marcucci, Lorenzo
    Cerri, Elisa
    Allegrini, Giacomo
    Andreuccetti, Michele
    Brunetti, Isa Maura
    Michelotti, Andrea
    Ricci, Sergio
    Falcone, Alfredo
    ANNALS OF ONCOLOGY, 2004, 15 : 86 - 87
  • [7] Survival outcomes in US patients with metastatic colorectal cancer (mCRC)
    Knopf, Kevin
    Iqbal, Sheikh Usman
    Thompson, Stephen F.
    Malangone, Elisabetta
    Gorritz-Kindu, Magdaliz
    Stern, Lee
    Sherman, Steven A.
    Naoshy, Sarah
    Wooten, Michael
    Andria, Michael L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [8] SURGICAL RESECTION OF LIVER METASTASES AND SURVIVAL OUTCOMES METASTATIC COLORECTAL CANCER (MCRC)
    Adda, Bounedjar
    Khelifa, Bendjebbar
    Haoui, Messaouda
    Kada, Boualaga
    El Mehdi, Si Ahmed
    ANNALS OF ONCOLOGY, 2014, 25
  • [9] ASO Author Reflections: R0 Resection and Targeted Therapy for Colorectal Peritoneal Metastasis
    Dai Shida
    Annals of Surgical Oncology, 2018, 25 : 842 - 843
  • [10] ASO Author Reflections: R0 Resection and Targeted Therapy for Colorectal Peritoneal Metastasis
    Dai Shida
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 842 - 843
12345